A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

NCT07143968 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
HIV (Human Immunodeficiency Virus)

Interventions

DRUG: Resmetirom
DRUG: Placebo Control

Sponsor

Naga P. Chalasani